DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 50576 - 50600 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▲ Gene Name UniProt ID
C0376358 Malignant neoplasm of prostate ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0006826 Malignant Neoplasms ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0027651 Neoplasms ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C1306459 Primary malignant neoplasm ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0033975 Psychotic Disorders ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0678222 Breast Carcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0018213 Graves Disease ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0005684 Malignant neoplasm of urinary bladder ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0919267 ovarian neoplasm ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0005586 Bipolar Disorder ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0036341 Schizophrenia ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0677886 Epithelial ovarian cancer ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0699885 Carcinoma of bladder ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C4721610 Carcinoma, Ovarian Epithelial ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0005695 Bladder Neoplasm ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C1140680 Malignant neoplasm of ovary ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0600139 Prostate carcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0279671 Cervical Squamous Cell Carcinoma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0023473 Myeloid Leukemia, Chronic ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0553723 Squamous cell carcinoma of skin ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0036421 Systemic Scleroderma ST3GAL1 6482 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 Q11201
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C0086651 Mucopolysaccharidosis, MPS-IV-A ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842
C3160718 PARKINSON DISEASE, LATE-ONSET ST3GAL2 6483 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 Q16842

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024